Table 2.
Clinical variables of SARS survivors
| Clinical variables | N = 102 | |
|---|---|---|
| SARS symptoms (mean ± S.D.) | 8.8 ± 4.7 | |
| Dyspnoea (%) | 15 (14.7) | |
| Respiratory rate (mean ± S.D.) | 18.9 ± 2.2 | |
| Initial oxygen saturation (mean ± S.D.) | 96.9 ± 2.0 | |
| Maximum oxygen requirement (%) | ||
| Nil | 56 (60.2) | |
| <2l/min | 19 (20.4) | |
| 3–5l/min | 5 (5.4) | |
| 6–10l/min | 0 | |
| >10l/min | 13 (14) | |
| Chest radiograph on admisson | ||
| Clear | 8 (7.9) | |
| Unilateral involvement | 78 (77.3) | |
| Bilateral involvement | 15 (14.8) | |
| ICU care (%) | 10 (9.8) | |
| Mechanical ventilation (%) | 3 (2.9) | |
| Pulse steroid (%) | 45 (44.1) | |
| Total dosage of pulse steroid in prednisone equivalent (mg) (median and quartile) | 2500 (2342.8, 5000.0) | |
| Accumulated dosage of corticosteroid in prednisone equivalent (mg) during acute phase (median and quartile) | 1662.5 (941.3, 3960.0) | |
| Duration of stay in acute hospital (mean ± S.D.) | 17.2 ± 6.1 | |
| Total duration of hospital stay (mean ± S.D.) |
20.5 ± 5.6 |
|